Please assess the completion status of the following clinical trial:

Trial Title: Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or Female 18 years or older~* Moderate to severe GL at maximum frown as assessed by the Investigator~* Moderate to severe GL at maximum frown as assessed by the subject~Exclusion Criteria:~* Previous use of any botulinum toxin in facial areas within 9 months prior to study treatment~* Female who is pregnant, breast feeding or intends to conceive a child during the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Active arm - QM1114-DP (Type: ACTIVE_COMPARATOR): a Botulinum Toxin Type A (BoNT-A)
- Inactive arm - Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).